A multidisciplinary centre within Cleveland Clinic's orthopaedics and rheumatology institute offering injection and non-surgical treatments aimed at preserving joints rather than replacing them.
The Joint Preservation Center is a department within Cleveland Clinic's orthopaedics and rheumatology institute, not a private cell therapy clinic. It is presented as a multidisciplinary team whose purpose is to reduce joint pain and improve joint function while avoiding surgery where possible — in other words, to preserve a joint rather than replace it. For a patient comparing providers, the key differences from a commercial clinic are that this sits inside a major academic health system, that the same team can offer conventional surgical options if preservation is not realistic, and that the centre describes itself as internationally active in research, pointing readers to its published work rather than to testimonials.
The treatments described combine conventional and biological approaches: physiotherapy, bracing, corticosteroid injections, and minimally invasive injection therapies including platelet rich plasma (PRP, prepared from the patient's own blood) and bone marrow concentrate. The centre is notably careful about terminology. It states that cellular therapies of this kind are sometimes called stem cell therapies, and that this misrepresents the biological definition of the term stem cell. That is a useful corrective for anyone who has been reading commercial marketing, and it signals a more conservative framing than most sites in this directory.
On cell sourcing the page identifies bone marrow concentrate as the cell-based option but does not set out the harvest site or the processing steps. Bone marrow concentrate is by its nature autologous (from the patient's own body), and no donor, umbilical cord or amniotic product is named anywhere. Even so, a prospective patient would reasonably want to ask where the marrow would be drawn from, how it is processed, and what the injection is expected to contain.
The conditions listed are specific and orthopaedic: osteoarthritis, osteonecrosis, tendinitis, scarring and movement restriction, anterior cruciate ligament tears, meniscal tears and hip labral tears. Physicians are listed by location across Ohio and Florida, with a Cleveland referral line of 216.444.5338. On cost, the centre states that insurance typically covers traditional therapies while some joint preservation treatments may not be covered, and that pricing and insurance are discussed at the time of diagnosis — clearer than most, though still not a published figure.
The centre lists specific orthopaedic diagnoses rather than pain by body region.
The centre names bone marrow concentrate as its cell-based option and states explicitly that calling such treatments stem cell therapies misrepresents the biological definition of the term stem cell.
The centre lists its physicians by location across Ohio and Florida, but the page reviewed does not set out individual credentials; a prospective patient would need to check the named clinician for their own location.
The centre operates within Cleveland Clinic, a large academic health system, with sites in Ohio and Florida and a central referral line of 216.444.5338 for appointments. Being part of such a system means the imaging, laboratory, rheumatology and surgical services a patient might need are available in the same institution, and that the team can move a patient to a conventional pathway if injection treatment is not suitable. The centre describes itself as internationally active in joint-preserving therapies and directs readers to its research publications. The page does not describe a dedicated cell-processing laboratory or state separate accreditation for the service, and does not mention languages, though an institution of this size would normally arrange interpreting on request.
No figures are published, but the position is set out more clearly than at most providers: the centre states that insurance typically covers traditional therapies, that some joint preservation treatments may not be covered, and that pricing and insurance are discussed at the time of diagnosis. A prospective patient should ask specifically whether the injection being proposed is covered by their plan, and if not, for a written price before agreeing to it.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.